Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Controlled drugs

Pharmacist prescribing of controlled drugs increases by 50% in a year

Pharmacist prescribing of controlled drug items has increased by more than 50% between 2017 and 2018, the Care Quality Commission (CQC) has found.

The CQC’s annual report, ‘The safer management of controlled drugs’, which details the essential issues in the area of controlled drugs, prescribing trends and recommendations for improving safety, also warned that community pharmacists should be “extra vigilant” to look out for anything unusual, such as the theft and misuse of controlled drugs and prescription pads.

The report, published on 9 July 2019,  said overall prescribing trends for controlled drugs in 2018 were broadly similar to 2017, with NHS primary care services prescribing 60 million controlled drug items — a decrease of 2% compared with 2017. 

Prescribing by non-medical prescribers increased, with nurse prescribing increasing by 10% and pharmacist prescribing by 56%.

For the first time, the report included national data on the number of reported incidents to NHS England controlled drugs accountable officers (CDAOs), who are responsible for all aspects of controlled drugs management within their organisations.

In 2018/2019, there were 2,899 unaccounted losses of controlled drugs reported to CDAOs, with methadone loss being the most common at 925 reported cases, followed by 640 reports of morphine and 386 reports of oxycodone.

Greater Manchester was the NHS region with the biggest number of reported losses, but the CQC has explained that this may be because it was the first area of England to begin using the controlled drug reporting tool, in 2013.

The report says data from the tool has allowed “persons and clinicians of concern” to be tracked and the “relevant organisations notified to support these individuals”.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20206787

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.